USPTO serial 98806107
ACCORD
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEEL, ALYSSA PALADINO
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ACCORD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,143*
Plus Government fees of $1,050
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele K. Robichaux
Michele K. Robichaux ODIN LAW AND MEDIA4208 Six Forks Rd., STE 1000RALEIGH, NC 27609United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, non-prescription drugs and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of medical conditions, namely, gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension; a full line of medicated and pharmaceutical preparations, namely, pharmaceutical preparations and substances for use in the prevention, treatment and management of cancer, autoimmune diseases, immunological deficiency syndromes in the nature of autoimmune diseases, and critical illnesses in the nature of immune system related diseases and disorders for use in connection with humans. | ACTIVE | — |
| 009 | Downloadable computer application software for mobile phones, namely, software for patients and caregivers to exchange, retrieve, view, and analyze medication, healthcare, and wellness information; Downloadable software for managing medical office inventories of pharmaceutical preparations. | ACTIVE | — |
| 035 | Pharmaceutical services, namely, processing orders for pharmacies and health care facilities and organizations; Distributorship services in the field of prescription pharmaceuticals and pharmaceutical preparations; wholesale store services featuring pharmaceuticals and pharmaceutical preparations | ACTIVE | — |
| 036 | Providing information and answers to questions for healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance; healthcare insurance services, namely, benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing information about healthcare insurance, patient financial assistance, and patient insurance reimbursement programs including enrollment requirements | ACTIVE | — |
| 041 | Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of Oncology, Immunology, and Critical Care | ACTIVE | — |
| 042 | Providing on-line, non-downloadable, Internet-based software applications for providing, exchanging, retrieving and analyzing health and healthcare information; providing a website featuring technology enabling users to exchange, retrieve and analyze health and healthcare information; Providing medical and scientific research information in the nature of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials; Providing scientific information in the fields of oncology, immunology, critical care and biosimilar medications | ACTIVE | — |
| 044 | Providing healthcare and medical information; Providing medical information in the fields of Oncology, Immunology, Critical Care and Biosimilars. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Accord Healthcare, Inc.
- Other trademarks owned by Accord Healthcare, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACCORD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 27, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 27, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 27, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 28, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 28, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 6, 2024 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Nov 6, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 17, 2024 | NWAP | NEW APPLICATION ENTERED | — |